BTL Group achieved a turnover of CZK 11.7bn in 2021 (+72% y/y). The
medical equipment manufacturer said that half of the total is made up of
medical devices in the field of aesthetic medicine, with other fields of
physiotherapy and cardiology sharing the other half. The aesthetic medicine
device called EMSCULPT NEO contributed significantly to the increase in sales.
In total, the Group produced almost 26,000 devices in 2021 for all three
disciplines in which it operates. BTL Medical Technologies CEO Tomáš Drbal said
that further strong investments in development and production technologies are
planned for 2022.
news | ČIA news
Czech Trade and Czech Invest Sydney